0001209191-21-023352.txt : 20210326 0001209191-21-023352.hdr.sgml : 20210326 20210326204031 ACCESSION NUMBER: 0001209191-21-023352 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210324 FILED AS OF DATE: 20210326 DATE AS OF CHANGE: 20210326 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Plat Francis CENTRAL INDEX KEY: 0001772290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38899 FILM NUMBER: 21779188 MAIL ADDRESS: STREET 1: C/O MILESTONE PHARMACEUTICALS, INC. STREET 2: 1111 DR. FREDERIK-PHILIPS BLVD., STE 420 CITY: MONTR?AL STATE: A8 ZIP: H4M 2X6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Milestone Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001408443 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD STREET 2: SUITE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 BUSINESS PHONE: (514) 336-0444 MAIL ADDRESS: STREET 1: 1111 DR. FREDERIK-PHILIPS BLVD STREET 2: SUITE 420 CITY: MONTREAL STATE: A8 ZIP: H4M 2X6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-03-24 0 0001408443 Milestone Pharmaceuticals Inc. MIST 0001772290 Plat Francis C/O MILESTONE PHARMACEUTICALS INC. 1111 DR. FREDERIK-PHILIPS BLVD, STE 420 MONTR?AL A8 H4M 2X6 QUEBEC, CANADA 0 1 0 0 Chief Medical Officer Employee Stock Option (right to buy) 6.26 2021-03-24 4 A 0 130000 0.00 A 2031-03-24 Common Shares 130000 130000 D One-fourth (1/4th) of the shares subject to the option vest on March 24, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date. /s/ Eric Popp, Attorney-in-Fact 2021-03-26